VBLT - Vascular Biogenics proposes capital raise

Vascular Biogenics (VBLT) announces that it intends to offer and sell ordinary shares and pre-funded warrants to purchase shares in an underwritten public offering.Expects to grant the underwriters a 30-day option to purchase up to an additional 15% of aggregate number of shares plus the shares underlying any pre-funded warrants.Intends to use the net proceeds from the offering for working capital and other general corporate purposes.Further financial details of the offering were not disclosed.Shares down nearly 8% post market.

For further details see:

Vascular Biogenics proposes capital raise